Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Leukemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00875745
What this trial is testing

Combination of Sorafenib and Vorinostat in Poor-risk Acute Myelogenous Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS)

Who this might be right for
Leukemia, Myeloid, AcuteLeukemia, Promyelocytic, AcuteMyelodysplastic Syndromes
Indiana University 15
Not applicableUnknownNCT06450145
What this trial is testing

Evaluate the Efficacy and Safety of Interferon-α Combined With ATO in the Treatment of Arsenic-resistant APL

Who this might be right for
Tumour
Zhejiang Provincial People's Hospital 15
Early research (Phase 1)UnknownNCT06027853
What this trial is testing

Natural Killer(NK) Cell Therapy Targeting CLL1 in Acute Myeloid Leukemia

Who this might be right for
AML, Adult
Zhejiang University 24
Large-scale testing (Phase 3)Study completedNCT00022737
What this trial is testing

Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Children With Acute Lymphoblastic Leukemia

Who this might be right for
Childhood Acute Lymphoblastic Leukemia in RemissionRecurrent Childhood Acute Lymphoblastic Leukemia
National Cancer Institute (NCI) 220
Not applicableUnknownNCT06335277
What this trial is testing

Total Body Irradiation Treatments for Patients Treated at European Institute of Oncology

Who this might be right for
LeukemiaLeukemia, ChronicLeukemia, Acute+2 more
European Institute of Oncology 50
Early research (Phase 1)Ended earlyNCT05609942
What this trial is testing

Study of Elenestinib (BLU-263) in Advanced Systemic Mastocytosis (AdvSM) and and Other KIT Altered Hematologic Malignancies

Who this might be right for
Advanced Systemic Mastocytosis
Blueprint Medicines Corporation 9
Not applicableUnknownNCT02489929
What this trial is testing

Evaluation of Cytidine Deaminase for Patient Suffering of a Myelodysplastic Syndrom or an AML Treated by Azacytidine

Who this might be right for
Myeloid LeukemiaMyelodysplastic Syndromes
Assistance Publique Hopitaux De Marseille 35
Not applicableActive Not RecruitingNCT00898456
What this trial is testing

Multidrug Resistance Genes in Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
Alliance for Clinical Trials in Oncology 600
Early research (Phase 1)Study completedNCT01246622
What this trial is testing

Lenalidomide and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+4 more
Roswell Park Cancer Institute 32
Early research (Phase 1)Ended earlyNCT03904251
What this trial is testing

CPX-351 and Gemtuzumab Ozogamicin in Treating Patients With Relapsed Acute Myeloid Leukemia

Who this might be right for
Acute Myelogenous Leukemia
Jonsson Comprehensive Cancer Center 13
Large-scale testing (Phase 3)Study completedNCT01497002
What this trial is testing

Comparison of the OSHO Protocol to a Standard Arm Protocol of the German AML Intergroup in Patients With AML>60a

Who this might be right for
Acute Myeloid Leukaemia
University of Leipzig 1,222
Large-scale testing (Phase 3)Study completedNCT00015873
What this trial is testing

Comparison of Different Combination Chemotherapy Regimens in Treating Infants With Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
Dutch Childhood Oncology Group 350
Early research (Phase 1)Study completedNCT01256073
What this trial is testing

A Safety and Tolerability Extension Trial Assessing Repeated Dosing of Anti-KIR (1-7F9) Human Monoclonal Antibody in Patients With Acute Myeloid Leukaemia

Who this might be right for
Acute Myeloid Leukemia
Innate Pharma 21
Early research (Phase 1)Active Not RecruitingNCT01044069
What this trial is testing

Precursor B Cell Acute Lymphoblastic Leukemia (B-ALL) Treated With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19

Who this might be right for
LeukemiaAcute Lymphoblastic Leukemia
Memorial Sloan Kettering Cancer Center 93
Early research (Phase 1)Study completedNCT00926731
What this trial is testing

Study to Assess the Safety and Tolerability of AZD1152 in Combination With Low Dose Cytosine Arabinoside (LDAC)

Who this might be right for
Acute Myeloid Leukemia
AstraZeneca 4
Early research (Phase 1)Study completedNCT03125239
What this trial is testing

Combination Merestinib and LY2874455 for Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Relapsed Adult Acute Myeloid LeukemiaRefractory Adult Acute Myeloid Leukemia
Jacqueline Garcia, MD 16
Early research (Phase 1)Not Yet RecruitingNCT07814339
What this trial is testing

Hydrochloroquinine & Decitabine With Venetoclax in AML

Who this might be right for
Acute Myeloid Leukemia
Rutgers, The State University of New Jersey 18
Testing effectiveness (Phase 2)UnknownNCT04248595
What this trial is testing

Study of Azacitidine Combined With Homoharringtonie Based Regimens in AML

Who this might be right for
Acute Myeloid Leukemia
Ge Zheng 100
Testing effectiveness (Phase 2)UnknownNCT02717884
What this trial is testing

Study of Sensitization of Non-M3 AML Blasts to ATRA by Epigenetic Treatment With Tranylcypromine (TCP)

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Michael Luebbert 60
Not applicableUnknownNCT02156297
What this trial is testing

Sorafenib to Treat FLT3-ITD AML

Who this might be right for
Acute Myeloid LeukemiaFLT3-ITD Mutation
The First Affiliated Hospital of Soochow University 100
Next Page